|
參考文獻 1.Jiangsu New Medical College. Dictionary of Chinese Crude Drugs (1985) Scientific and Technological Press: Shanghai, 99.1250-1252. 2.National Phamacopeia Committee (2000) The Pharmacopeia of PRC (Part.1, 2000 Edition). Chemical Industry Press, Peking, China, 163-164. 3. Wang A (1986) A handbook of Herbal Medicine. Wen Kuan Publishing Co., Ltd. Taipei, 102-103. 4. Wu XY, Qin GW, Cheung KK, Cheng KF (1997) New alkaloids from Isatis indigotica. Tetahedron 53(39): 13323-13328. 5.Huang QS, Yoshihira K, Natori S (1981) Isolation of 2-hydroxy-3-buteny1 thiocyanate, epigotin and adenosine from Banlangev, Isatis indigotica root. Planta Med 42: 308-310. 6.Ho YL, Chang YS (2002) Studies on the antinociceptive, anti-inflammatory and antipyretic effects of Isatis indigotica root. Phytomedicine 9: 419-424. 7.Peiris JS, Lai ST, Poon LL et al (2003) Coronavirus as a possible cause of severe acute respiratory ryndrome. Lancet 361:1319-1325. 8.Ksiazek TG, Erdman D, Goldsmith CS et al (2003) A novel coronavirus associated with severe acute sespiratory syndrome. N Engl J Med 348: 1953-1966. 9.Drosten C, Gunther S, Preiser W et al (2003) Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348: 1967-1976. 10.Reilley B, Van Herp M, Sermand D, Dentico N (2003) SARS and Carlo Urbani, N Engl J Med 348:1951-1952. 11. Shih M C, Peck K, Chan W L, Chu Y P, Chen J C, Tsai C H, Chang J G (2005) SARS-CoV Infection Was from at Least Tow Origins in the Taiwan Area. Intervirology 48:124-132. 12.Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354: 610-621. 13.Wang L, Zhang X, Farrar WL, Yang X (2004) Transcriptional crosstalk between nuclear receptors and cytokine signal transduction pathways in immunity. Cell Mol Immunol 1: 416-424. 14.Giliani S, Mella P, Savoldi G, Mazzolari E (2005) Cytokine-mediated signaling and early defects in lymphoid development. Curr Opin Allergy Clin Immunol 5: 519-524. 15.Lee MS (2002) Cytokine synergism in apoptosis: its role in diabetes and cancer. J Biochem Mol Biol 35: 54-60. 16.Kawai T, Akira S (2006) Innate immune recognition of viral infection. Nat Immunol 7: 131-137. 17.Takahama Y (2006) Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol 6: 127-35. 18. Sigal LH (2005) Basic science for the clinician 34: Interleukins of current clinical relevance (part Ⅱ). J Clin Rheumatol 11(1):34-9. 19. Pestka S, Kuause CD, Walter MR (2004) Interferons, interferon-like cytokines, and their receptors. Immunol Rev. 202:8-32. 20. So T, Lee SW, Croft M (2006) Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity. Int J Hematol 83(1):1-11. 21. Goodsell DS (2006) The molecular perspective: tumor necrosis factor. Oncologist 11(1):83-4. 22. Letai A (2006) Growth factor withdrawal and apoptosis: the middle game. Mol Cell 17;21(6):728-30. 23. De Pascalis B, Bianchi A, Satta MA, Lupascu A, Mentella MC, Leo D, Fiore F, Fedeli P, Pontecorvi A, Pola P, Melina D, Gasbarrini A, De Marinis L, Armuzzi A (2006) Growth hormone in inflammatory bowel disease. Eur Rev Med Pharmacol Sci. 10(1):13-6. 24. Steinke JW, Borish L (2006) Ctokines and chemokines. J Allergy Clin Immunol. 117(2 Suppl Mini-Primer) S441-5. 25. Layton JE, Hall NE (2006) The interaction of G-CSF with its receptor. Front Biosci 11:3181-9. 26. Kaushansky K (2006) Lineage-specific hematopoietic growth factors. N Engl J Med. 354(19):2034-45. 27. Cianci R, Cammarota G, Raducci F, Pandolfi F (2005) The impact of biological agents interfering with receptor/ligand binding in the immune system. Eur Rev Med Pharmacol Sci. 9(6):305-14. 28. Nishimoto N (2005) Cytokine signal regulation and autoimmune disorders. Autoimmunity. 38(5):359-67. 29. Hideshima T, Podar K, Chauhan D, Anderson KC (2005) Cytokines and signal transduction. Best Pract Res Clin Haematol. 18(4):509-24. 30. Fas SC, Fritzsching B, Suri-Payer E, Krammer PH (2006) Death receptor signaling and its function in the immune system. Curr Dir Autoimmun 9:1-17. 31. Salazar-Mather TP, Hokeness KL (2006) Cytokine and chemokine networks: pathways to antiviral defense. Curr Top Microbilo Immunol. 303:29-46. 32. Ragoussis J, Elvidge G (2006) Affymetrix GeneChip system: moving from research to the clinic. Expert Rev Mol Diagn. 6(2):145-52. 33. Vissers LE, Veltman JA, van Kessel AG, Brunner HG (2005) Identification of disease genes by whole genome CGH arrays. Hum Mol Genet. 14 Spec No. 2:R215-23. 34. Quackenbush J (2006) Microarray analysis and tumor classification. N Engl J Med. 354(23):2463-72. 35. Ranz JM, Machado CA (2006) Uncovering evolutionary patterns of gene expression using microarrays. Trends Ecol Evol. 21(1):29-37. Epub 2005 Sep 21. 36. Shai RM (2006) Microarray tools for deciphering complex diseases. Front Biosci. 1;11:1414-24. 37. Li J, Burmeister M (2005) Genetical genomics: combining genetics with gene expression analysis. Hum Mol Genet. 14 Spec No. 2:R163-9. 38. Klein D (2002) Quantificatiojn using real-time PCR technology: applications and limitations TRENDS in Molecular Medicine 6,257-260. 39. Yamagata T, Ichinose M (2006) Agents against cytokine synthesis or receptors. Eur J Pharmacol. 533(1-3):289-301. Epub 2006 Feb 2. 40 Wagner G, Laufer S (2006) Small molecular anti-cytokine agents. Med Res Rev 26(1):1-62. 41. Spiegel M, Weber F (2006) Inhibition of cytokine gene expression and induction of chemokine genes in non-lymphatic cells infected with SARS coronavirus. Virol J 3: 17. 42.Yen YT, Liao F, Hsiao CH, Kao CL, Chen YC, Wu-Hsieh BA (2006) Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro. J Virol 80: 2684-2693. 43.Okabayashi T, Kariwa H, Yokota S, Iki S, Indoh T, Yokosawa N, Takashima I, Tsutsumi H, Fujii N (2006) Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections. 78: 417-424. 44.Sheng WH, Chiang BL, Chang SC, Ho HN, Wang JT, Chen YC, Hsiao CH, Hseuh PR, Chie WC, Yang PC (2005) Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome. J Formos Med Assoc 104: 715-723. 45.Ziegler T, Matikainen S, Ronkko E, Osterlund P, Sillanpaa M, Siren J, Fagerlund R, Immonen M, Melen K, Julkunen I (2005) Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells. J Virol 79: 13800-13805. 46.Lo AW, Tang NL, To KE (2006) How the SARS coronavirus causes disease: host or organism? J Pathol 208: 142-151. 47.Cheung CY, Poon LL, Ng IH, Luk W, Sia SF, Wu MH, Chan KH, Yuen KY, Gordon S, Guan Y, Peiris JS (2005) Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J virol 79: 7819-7826. 48.Law HK, Cheung CY, Ng HY, Sia SF, Chan YO, Luk W, Nicholls JM, Peiris JS, Lau YL (2005) Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. Blood 106: 2366-2374. 49.Jiang Y, Xu J, Zhou C, Wu Z, Zhong S, Liu J, Luo W, Chen T, Qin Q, Deng P (2005) Characterization of cytokine/chmokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med 171: 850-857. 50.Reghunathan R, Jayapal M, Hsu LY, Chang HH, Tai D, Leung BP, Melendez AJ (2005) Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome. BMC Immunol 6:2. 51.Zhang Y, Li J, Zhan Y, Wu L, Yu X, Zhang W, Ye L, Xu S, Sun R, Wang Y, Lou J (2004) Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect Immun 72: 4410-4415. 52.Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH, Lit LC, Hui DS, Chan MH, Chung SS, Sung JJ (2004) Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 136: 95-103. 53.Ng PC, Lan CW, Li AM, Wong CK, Cheng FW, Leuug TF, Hon EK, Chan IH, Li CHK, Fung KS, Fok TE (2004) Inflammatory cytokine profile in children with severe acute respiratory syndrome. Pediatrics 113:e7-14. 54.Hsiang CY, Hsieh CL, Wu SL, Lai IL, HoTY (2001) Inhibitory effect of anti-pyretic and anti-inflammatory herbs on herps simplex virus replication. Am J Chin Med 29: 459-467. 55. Chen JJ, Wu R, Yang PC, Huang JY, Sher YP, Han MH, Kao WC, Lee PJ, Chiu TF, Chang F, Chu YW, Wu CW, Peck K (1998). Profiling expression patterns and isolating differentially expressed genes by cDNA microarray system with colorimetry detection. Genomics 51(3):313-24. 56. Chen JJ, Peck K, Hong TM, Yang SC, Sher YP, Shih JY, Wu R, Cheng JL, Roffler SR, Wu CW, Yang PC (2001) Global analysis of gene expression in invasion by a lung cancer model. Cancer Res. 61(13):5223-30. 57. Chou CC, Chen CH, Lee TT, Peck K (2004) Optimization of probe length and the number of probes per gene for optimal microarray analysis of gene expression. Nucleic Acids Res. 32(12):e99. 58. Hsieh-Li HM, Chang JG, Jong YJ, Wu MH, Wang NM, Tsai CH, Li H (2000) A mouse model for spinal muscular atrophy. Nature Genet. 24:66-70. 59.Yeh KT, Yang MY, Liu TC, Chen JC, Chan WL, Lin SF, Chang JG (2005) Abnormal expression of Period 1 (PER1) in endometrial carcinoma. J Pathol 206: 111-120. 60.Dodelet VC, Pasquale EB (2000) Eph receptors and ephrin ligands: embryogenesis to tumorigenesis. Oncogene 19: 5614-5619. 61.Aasheim HC, Terstappen LW, Logtenberg T (1997) Regulated expression of the Eph-related receptor tyrosine kinase Hek11 in early human B lymphopoiesis. Blood 90: 3613-3622. 62.Aasheim HC, Munthe E, Funderud S, Smeland EB, Beiske K, Logtenberg T (2000) A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytes. Blood 95: 221-30. 63.Shimoyama M, Matsuoka H, Tamekane A, Ito M, Iwata N, Inoue R, Chihara K, Furuya A, Hanai N, Matsui T (2000) T-cell-specific expression of kinase-defective Eph-family receptor protein, EphB6 in normal as well as transformed hematopoietic cells. Growth Factors 18: 63-78. 64.Kullander K, Klein R (2002) Mechanisms and functions of Eph and ephrin signalling.Nat Rev Mol Cell Biol 3: 475-86. 65.Miao H, Wei BR, Peehl DM, Li Q, Alexandrou T, Schelling JR, Rhim JS, Sedor JR, Burnett E, Wang B (2001) Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat Cell Biol 3: 527-30. 66.Sharfe N, Freywald A, Toro A, Roifman CM (2003) Ephrin-A1 induces c-Cbl phosphorylation and EphA receptor down-regulation in T cells. J Immunol 170: 6024-6032. 67.Huang C C, Chuang J H, Huang L L, Chou M H, Wu C L, Chen C M, Hsien C S, Lee S Y, and Chen C L, (2004) The human Delat-like l homologue is implicated in the progression of liver fibrosis in biliary atresia. J Pathol., 202:172-179. 68.Moon YS, Smasit CM, Lee K, Villena JA, Kim KH, Yun EJ, Sul HS (2002) Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity. Mol Cell Biol 22: 55885-5592. 69.Lu Q, Lemke G (2001) Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 293: 306-311. 70.Cohen PL, Caricchio R, Abraham V, Camenisch TD, Jennette JC, Roubey RA, Earp HS, Matsushima G, Reap EA (2002) Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med 196: 135-140. 71.Scott RS, McMahon EJ, Pop SM, Reap EA, Garicchio R, Cohen PL, Earp HS, Matsushima GK (2001) Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411: 207-11. 72.Viancllo F, Papeta N, Chen T, kraft P, White N, Hart WK, Kircher MF, Swart E, Rhee S, Palu G, Irimia D, Toner M, Weissleder R, Poznansky MC (2006) Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control. J Immunol 176: 2902-2914. 73.Yasumoto K, Koizumi K, Kawashima A, Saitoh Y, Arita Y, Shinohara K, Minami T, Nakayama T, Sakurai H, Takahashi Y, Yoshie O, Saiki I (2006) Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res. 66 : 2181-2187. 74.Gomperts BN, Belperio JA, Rao PN, Randell SH, Fishbein MC, Burdick MD, Strieter RM (2006) Circulating progenitor epithelial cells traffic via CXCR4/CXCL12 in response to airway injury. J Immunol 176: 1916-1927. 75.Villarino AV, Stumhofer JS, Saris CJ, Kastelein RA, de Sauvage FJ, Hunter CA (2006) IL-27 limits IL-2 production during Th1 differentiation. J Immunol 176: 237-247. 76.Owaki T, Asakawa M, Morishima N, Hata K, Fukai F, Matsui M, Mizuguchi J, Yoshimoto T (2005) A role for IL-27 in early regulation of Th1 differentiation. J Immunol 175: 2191-200. 77.Hunter CA (2005) New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 5: 521-531. 78.Chiyo M, Shimozato O, Yu L, Kawamura K, Iizasa T, fujisawa T, Tagawa M (2005) Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. Int J Cancer 115: 437-442. 79.Villarino AV, Huang E, Hunter CA (2004) Understanding the pro- and anti-inflammatory properties of IL-27. J Immunol 173: 715-720. 80.Chen L, Lin T, Zhang H, Su Y (2005) Immune responses to foot-and-mouth disease DNA vaccines can be enhanced by coinjection with the Isatis indigotica extract. Intervirology 48: 207-212. 81.Lin CW, Tsai FJ, Tsai CH, Lai CC, Wan L, Ho TY, Hsieh CC, Chao PD (2005) Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res 68: 36-42. 82.Molina P, Tarraga A, Gonzalez-Tejero A, Rioja I Ubeda A, Terencio MC, Alcaraz MJ, (2001) Inhibition of leukocyte functions by the alkaloid isaindigotone from Isatis indigotica and some new synthetic derivatives. J Nat Prod 64: 1297-1300. 83.Mak NK, Leung CY, Wei XY, Shen XL, Wong RN, Leung KN, Fung MC (2004) Inhibition of RANTES expression by indirubin in influenza virus-infected human bronchial epithelial cells. Biochem Pharmacol 67: 167-74. 84.Eisenbrand G, Hippe F, Jakobs S, Muehlbeyer S (2004) Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine. J Cancer Res Clin Oncol 130: 627-635.
|